Wang et al. showed that p38gamma-MAPK promotes pancreatic cancer by activating PFKFB3 and GLUT2 through the KRAS oncogene signaling and aerobic glycolysis (Wang et al., 2020). The gene discussed is KRAS; the disease is familial pancreatic carcinoma.